Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829789 · ClinicalTrials.gov registry record · NA

Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth

A NA study of Substance Use Disorders and Treatment Refusal, sponsored by Oregon Research Institute.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01829789: Completed NA study of Substance Use Disorders and Treatment Refusal, sponsored by Oregon Research Institute.

NCT01829789 is a NA study of Substance Use Disorders and Treatment Refusal that has completed, run by Oregon Research Institute. The registered enrollment target is 60 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829789, a NA study of Substance Use Disorders and Treatment Refusal, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy and cost-effectiveness of Community Reinforcement Training (CRT) provided in a group therapy format. The goals of CRT are to teach parents behavioral and communication skills to influence their youth's drug use and encourage them to enter treatment. Thirty parents will be randomly assigned to Group CRT and 30 will be randomly assigned to traditional, Individual CRT. Youth engaged in treatment will receive individual Cognitive Behavioral Therapy. Families are assessed for adolescent substance use and other areas of individual and family functioning. It is expected that Group CRT will be more effective for encouraging youth entry into treatment and improving parental functioning.

Primary Outcome

An adolescent may enter the CBT treatment program ("treatment engagement") at any point during the 4-month time period after his or her parents begin I-CRT or G-CRT therapy.

Interventions

  • BEHAVIORAL Group Community Reinforcement Training for Parents
  • BEHAVIORAL Individual Community Reinforcement Training for Parents

Study Locations (1)

Oregon

  • Center for Family and Adolescent Research - Portland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-04
Est. Completion 2016-03
Phase NA
Oregon Research Institute

62 total trials

What the finished NCT01829789 record still lists

NCT01829789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Group Community Reinforcement Training for Parents is the first listed.

NCT01829789 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT01829789 about?

NCT01829789 is a clinical study titled "Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth". The purpose of this study is to test the efficacy and cost-effectiveness of Community Reinforcement Training (CRT) provided in a group therapy format. The goals of CRT are to teach parents behavioral and communication skills to influence their youth's drug use and encourage them to enter treatment. ...

What is the current status of trial NCT01829789?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-04. Estimated completion is 2016-03.

What conditions does trial NCT01829789 study?

This clinical trial studies the following conditions: Substance Use Disorders, Treatment Refusal.

What interventions are being tested in trial NCT01829789?

The interventions under investigation include: Group Community Reinforcement Training for Parents (BEHAVIORAL), Individual Community Reinforcement Training for Parents (BEHAVIORAL).

Who is sponsoring clinical trial NCT01829789?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01829789 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01829789's enrollment target sits among peer trials

60 63rd of 93 higher than 29 of 93 other Substance Use Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01829789, the US trial registry maintained by the National Library of Medicine. NCT01829789 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.